OSRH

Repsj1

$OSRH very oversold, good swing opp

BagHoldingBuru

Lets play a game... If you had 5k of fun money that if you lost, ovbiously you'd be pissed but it wouldn't be the end of the world because thats just a bonus or commission you made at work. What would you invest it in for a quick 30-90 day "major" profit. Legit not hail Mary type plays but real stocks with momentum or potential catalyst that could net a decent return. I have enough money tied up in other investments and unfortunately crypto (sol and eth...ughhhh) so im just looking for an unexpected potential home run with the money I can afford to lose. I bought OSRH yesterday and took a beatdown. Any advice from the penny stock degen fan is greatly appreciated

BagHoldingBuru

OSRH was a steaming pile of sheeeeet today. Thanks to whoever posted that convincing info this morming. Got me...hook, line and stinker.

BagHoldingBuru

I do gets confused from time to time...This being one of those times. OSRH announced decent to good news today...should have been somewhat of a catalyst for a move up...the move up was premarket and then instantly tanked. Avg volume is 17 million, current volume is 1.7 million. Where did the volume go? Was this buy rumor sell the news? Legit thought I was eating crab legs tonight. Now I gotta buy imitation crab meat instead.

SpiritedLock6993

OSRH- it’s not that sexy but it’s .50 with twice affirmed Emerging Growth Research value price of $10.00. Why not?

BagHoldingBuru

Come on OSRH...Do Sum Tin!

Due-Papaya-6217

OSRH! News announced 30m IP purchase

Remigius

Bought OSRH

BeginningRoad1661

OSRH news and running

Secret_Block_8755

OSRH going a little silly, volume rising on news. Price is very spread at the moment.

Repsj1

Yup also watching OSRH

BeginningRoad1661

OSRH is about to take off

Repsj1

I called GVH I called BGDE I called XRX and now my portfolio is 50% of $OSRH

BeginningRoad1661

OSRH finally hitting a reversal

SpiritedLock6993

OSRH

SpiritedLock6993

OSRH

Celestial_Surfing

OSRH. Saw those bigly numbers on their drug deal. 

BeginningRoad1661

I’m nearly over OSRH at this point

Secret_Block_8755

OSRH is currently at a good entry. Do some DD, but essentially aiming for $1 soon an long term PT is $10 I'm also in SEGG and SRXH

Repsj1

OSRH nice chart

BeginningRoad1661

OSRH 👀

SignificanceLate7002

No problem. This is a good one to watch for now. OSRH is also a good one to track. The $815M license agreement looks like it'll be dependant on their VXM01 getting FDA approval. Could be a long wait.

Reasonable_Water6232

Thank You for that. So maybe  wasnt the smartest to get into that. Been sitting on my OSRH for like a month and hasnt moved really at all so decided to get into ALP because someone yelled it out over here.

EmbarrassedPart1256

Gotta be something to the $OSRH then, $CAPS is the same way, literally kept in the dark seemingly almost purposefully. We’re either onto something or we’re crazy. I will say that their claim that they won’t need an RS is bold. Short sellers can absolutely destroy a stock. Just look at $CAPS; the fundamentals simply don’t align with the stock, management doesn’t agree with the price, etc, & yet it’s just being held down as much as possible. $CAPS has a RS up for vote (it’ll get approved because insiders have a controlling interest) & I think that’s proactive.

BeginningRoad1661

sold some SRXH finally today and it fells good even if I sold a little early. I know it will come back down IXHL has given back all gains and then some. That’s expected. I’m a buyer under 3.60 Still holding some OSRH, not sure what to make of that honestly. no RS confirmed, $815 million dollar deal…market doesn’t seem to care

Repsj1

OSRH Red to green again, same as yesterday. Hold at least till 1

BeginningRoad1661

OSRH

EmbarrassedPart1256

$CAPS is on par with $OSRH in terms of being undervalued. Management has said it may times in multiple FAQs 🤙 They’re not considering bankruptcy, they’re not aggressively diluting to stay in business, & business is booming. It just doesn’t have eyes (yet)…

gaymerkid123

OSRH

Repsj1

OSRH guys

Repsj1

Don’t miss OSRH run today, it is starting

Repsj1

OSRH all day runner after this news imo

BeginningRoad1661

OSRH just broke resistance

Repsj1

OSRH starting to heat up after news

Repsj1

OSRH announced no reverse split before August so this has to be at least a 2x from todays prices as they have to hit 1 dollar

BeginningRoad1661

OSRH

BeginningRoad1661

OSRH will continue up tomorrow

Secret_Block_8755

Good job I took profits on OSRH

mightyblend

I knew I shouldn't get back into OSRH, but here we are

Repsj1

Get in OSRH before AH! You gonna be sorry

BeginningRoad1661

OSRH that mid .60s dip was your last chance

BeginningRoad1661

OSRH wants .80

BeginningRoad1661

OSRH wants .80

Outside-Jello6336

Thanks to the people who called out OSRH and SYNR I’m gaining money

Repsj1

Hello downvoters OSRH? Where are you? Oh, Im up 20%

Repsj1

If OSRH breaks 0.71-0,72 were off 🚀

Outside-Jello6336

I’m in OSRH and snyr

Repsj1

Bots downvoting OSRH post is a good thing 🤑

Repsj1

Somebody just bought 10M shares of OSRH 🤑🤑

Repsj1

$OSRH - unreal bio setup. Load up! 🎯 PT: $10+ stock at minimum. 🔹️$815M DEAL!!! 🔹️$15M where BCME is forced to BUY shares at $10 if OSRH needs money. 🔹️$30M upfront; half cash and half digital assets 🔹️100% royalties AFTER BCME gets their money back + small extra. 🔹️61% of shares are held by insiders/tutes. 🔹️29.7% is held by BCME. 🔹️VXM01 is 2b/3 trial ready. 🔹️$2.18M cash-in-hand + $80M credit line 🔹️4 subsidiaries; 3 verticals.

BeginningRoad1661

OSRH printing again today. Keep chasing Chinese pumps tho

WailingWarbler

OSRH might hit 1$ today ah

Repsj1

OSRH sudden green big candles

Repsj1

Remember OSRH news? It has been manipulated down, bit things are about to turn I think.

BeginningRoad1661

OSRH told you

WailingWarbler

If anyone's interested OSRH might pop off tomorrow following a speech. I put a couple hundred bucks in.

BeginningRoad1661

OSRH for tomorrow morning

WailingWarbler

I put a couple 100 bucks into OSRH possible shrtSqueeze tomorrow

BeginningRoad1661

OSRH .80 retest coming

BeginningRoad1661

OSRH 👀

Repsj1

Yesterday scalped OSRH perfectly, today eying NXXT for a 10% scalp

spiderman96

Need OSRH AND XRX to have a big day

spiderman96

So OSRH is gonna run this morning

nickyno1

How long? Not exactly a penny stock (But I guess it was a few months ago) : NOK Currently at close to its historic lows. Earning is next week: SOUN Slightly risky as its not in compliance: OSRH

Repsj1

Kinda wanna buy in again for OSRH but cant be greedy..

Repsj1

OSRH 1 tomorrow

Jasmine7707

OSRH

Repsj1

OSRH heating up again

Repsj1

OSRH 850M deal, they get 100% royalties

Repsj1

In OSRH!

Outside-Jello6336

Anyone on OSRH?

Reasonable-Hedgehog6

OSRH too

AxelFooley

I'm sick of all the "trust me bro" DD on reddit, so as many others, i built an agent that verifies claims based on factual data: # OSRH DD Verification — Verdict: HIGH CAUTION / Do Not Enter Here's the breakdown of what the Reddit DD gets right, what it distorts, and the structural red flags the author buried. # ✅ What's Factually Correct * **$815M deal is real.** OSRH executed a definitive global exclusive license agreement with BCM Europe AG for VXM01 development and commercialization, with BCME pledging its \~29.7% stake as collateral for milestone obligations of up to $815 million. [Pressrelease](https://www.pressrelease.com/news/osr-holdings-executes-definitive-815-million-global-license-agreement-for-vxm01) * **The $10 put option exists.** The agreement includes a put option under which OSRH may require BCME to purchase up to $15 million of OSRH common stock at $10.00 per share, exercisable no earlier than six months following the effective date. [Pressrelease](https://www.pressrelease.com/news/osr-holdings-executes-definitive-815-million-global-license-agreement-for-vxm01) The DD calls this a "valuation floor" — that's misleading (see below). * **Shares outstanding / market cap math** roughly checks out. Current market cap \~$15M at $0.46. # ❌ What's Wrong or Deliberately Misleading **1. "Sealed the deal" framing obscures the deal structure.** The DD presents this as OSRH *receiving* $815M. It's not. The milestone structure is weighted primarily toward clinical and development achievements [sec](https://www.sec.gov/Archives/edgar/data/0001840425/000121390026004199/ea027273801ex99-1_osrhold.htm) — meaning OSRH only collects if VXM01 clears Phase 3, gets regulatory approval, then achieves commercial milestones. That's a 5–10 year path with a high failure rate for oncology assets. The $815M is a theoretical maximum across a full lifecycle, not cash in the door. **2. The $30M upfront is also not clean cash.** OSRH acquires the full VXM01 IP from Vaximm AG under a $30 million asset purchase agreement [Pressrelease](https://www.pressrelease.com/news/osr-holdings-executes-definitive-815-million-global-license-agreement-for-vxm01) — meaning that $30M flows from OSRH *to* Vaximm to buy the IP it will then license out. That's a capital outflow, not inflow. **3. The "valuation floor" at $10 is fantasy math.** The put option lets OSRH *sell shares* to BCME at $10 — but only up to $15 million total. That's not a stock price floor. At 33M shares, $15M in buyback at $10 is 1.5M shares. It puts zero floor on the other 31.5M shares. The author is conflating "BCME must buy stock at $10 if OSRH triggers the put" with "the stock will go to $10." These are completely different things. **4. BCM Europe is not an independent institutional investor.** BCM Europe AG is a healthcare and blockchain investment firm based in Zug, Switzerland — and the founding organization behind Taekwondo Access Credit (TAC), a utility token adopted in the martial arts community. [PR Newswire](https://www.prnewswire.com/news-releases/osr-holdings-announces-strategic-roadmap-for-tokenization-under-reg-d-framework-in-partnership-with-bcm-europe-ag-302501191.html) This is a Zug crypto/blockchain entity that also holds a large OSRH stake, not a Royalty Pharma or Blackstone-caliber life sciences fund. The DD author omits this entirely. BCME is also a **related party** — the agreement constitutes a related party transaction and was approved by the board, including independent directors, following consideration of an independent fairness opinion. [PharmiWeb](https://www.pharmiweb.com/press-release/2026-04-29/osr-holdings-executes-definitive-815-million-global-license-agreement-for-vxm01-with-bcm-europe) Related party deals at micro-caps are a classic pump vector. **5. "Smart money shaking out weak hands" is narrative, not evidence.** Current price is $0.46 — *down -38% today* from yesterday's close of $0.74. The stock opened at $0.74 and is now back to the DD author's described "flush" level. This is not a controlled shakeout pattern; it's a micro-cap that spiked on news and is giving it all back. **6. No Phase 3 data cited for VXM01.** The press releases consistently call VXM01 "Phase 3-ready." Phase 3-ready ≠ Phase 3 complete ≠ Phase 3 approved. Glioblastoma has one of the worst oncology track records for new therapies. The DD doesn't mention this risk at all. # 🚨 Structural Red Flags |Flag|Severity| |:-|:-| |Micro-cap ($15M), 22 employees, no revenue|🔴| |BCME = related party + crypto token issuer (TAC/Taekwondo utility token)|🔴| |$815M milestone payments conditional on full clinical/regulatory/commercial success over many years|🔴| |Stock down -38% today after spiking on deal news|🔴| |$80M ELOC from "White Lion GBM Innovation Fund" — dilutive capital facility|🔴| |Blockchain tokenization of royalties ("OSRT security tokens", "TAC tokens") attached to a pharma licensing deal|🔴| |Put option presented as valuation floor when it's capped at $15M total|🟡| |No independent pharma partner signed — BCME must go find one|🟡| The ELOC is particularly damning. OSRH continues to draw from its $80 million ELOC from White Lion GBM Innovation Fund [PR Newswire](https://www.prnewswire.com/news-releases/osr-holdings-announces-strategic-roadmap-for-tokenization-under-reg-d-framework-in-partnership-with-bcm-europe-ag-302501191.html) — equity lines of credit at micro-caps are continuous dilution engines. Every draw issues new shares, suppressing price. This makes an upward "mega jump" structurally difficult unless a major pharma partner signs on, which hasn't happened and may not. # Bottom Line This DD reads as a promotion piece dressed in "I did the math" clothing. The core comparison — "$19M market cap vs $815M deal" — is technically real but functionally misleading, because the $815M is a milestone ladder that requires the company to survive, run successful trials, and secure commercial deals that BCME hasn't found yet. **This goes nowhere near a position.** Even if you were inclined to speculate, you'd need: 1. Evidence BCME has actual capital (not TAC tokens) to fund Phase 3 2. A named pharma sublicensee 3. Phase 3 trial design and timeline published 4. The stock to stabilize — it's down 38% today and hasn't held any level for 3+ consecutive days (your own re-entry rule applies here) Parking lot? No — this doesn't even qualify for the parking lot. There's no catalyst gate you can clearly define, no exit logic that makes sense at this volatility, and the counterparty credibility is genuinely questionable. Hard pass.

Van_19905

I pasted OPs tezt into Claude Let me dig into this. The thesis has several specific claims worth checking — the $815M deal, the share count, the $10 put option, and the actual state of OSR Holdings as a business. Let me check share count, financials, and any dilution risk before giving a verdict. I have what I need. Let me give you a clear-eyed read on this. You've spent enough time on rare-disease pharma rollups (Eton, etc.) and microcap screens that I'm going to skip the hand-holding and just call out where this thesis breaks. **The deal is real, but the math in the post is wrong on multiple counts.** **1. The "$815M deal" is not what it looks like.** Read the structure carefully: BCM Europe is OSRH's largest shareholder (~29.7%). This is a related-party transaction. BCME — not Big Pharma — is the licensee, and the $815M is *contingent milestone payments* from BCME tied to clinical/regulatory/commercial success on a Phase-3-ready oncology asset. BCME is a Swiss "investment entity" operating through "BCM Decentralized Science Investors I, LP" — i.e., a sponsor vehicle, not Roche. They're going to "engage leading global pharmaceutical partners to secure a sublicensing transaction." So the *actual* economic event the market should price is: probability-weighted milestones from a sublicense BCME hasn't yet found, minus BCME's recovered investment and preferred return, times the typical 5–15% Phase-3 oncology success rate. The Vaximm asset has been kicking around since 2010s-era trials in glioblastoma and pancreatic — it's not new. The fact that the board needed an Avance Life Sciences fairness opinion to approve it tells you this is structurally a financing dressed as a license. **2. Share count is wrong and dilution is brutal.** The post says ~33M shares. The Q3 10-Q (Sep 30, 2025) shows **23.67M outstanding, up from 2.16M at YE 2024** — that's a >10x increase in nine months from the business combination plus an $80M equity line of credit (ELOC) with White Lion Capital. ELOCs at this size on a $19M market cap company are a dilution machine; every uptick gets sold into. Plus the Nasdaq minimum bid price deficiency notice (grace period was until March 4, 2026 — worth checking current compliance status). Reverse split risk is real. **3. The "$10 put option" floor is misread.** OSRH can put **up to $15M of stock** to BCME at $10 — that caps at 1.5M shares, not the whole float. It's a small bridge-financing backstop, not a valuation floor. And BCME's pledge of its 29.7% stake as "collateral" for $815M of milestones is mostly theatre — that stake is worth ~$6M today, so it's not real security against $815M. **4. Cash position is critical.** $2.18M cash at Sep 30 against ~$13M nine-month net loss. They are burning ~$4M/quarter and were down to roughly six months of runway before this deal. The $30M asset purchase to acquire Vaximm IP from itself (Vaximm is a wholly-owned sub) and $30M development financing facility are circular — money has to come from somewhere, almost certainly the ELOC or BCME equity injections. More dilution incoming. **5. The "retail flush" narrative is the tell.** A $19M market cap stock dropping to $0.46 and bouncing to $0.69 isn't smart-money accumulation — it's noise on a few hundred thousand dollars of volume. There's no institutional sponsorship to "flush." **Bottom line.** This is a cash-strapped microcap that just did a related-party licensing deal with its largest shareholder, where the headline number is back-end-loaded contingent milestones on a Phase-3-ready asset that hasn't found a real pharma partner. The structure, the ELOC, the bid-price deficiency, and the related-party fairness-opinion mechanics all point to financial engineering to keep the lights on, not a mispriced compounder. A genuine Big Pharma licensing deal looks like Summit/Akeso ($500M upfront from Summit) or Nurix/Gilead — actual cash, named counterparty, no shareholder pledge theater. If you wanted to play it, the only rational frame is a lottery ticket on (a) BCME actually landing a real sublicense to a global pharma in the next 12–18 months, and (b) trial data being good. Both are low-probability. Sizing should reflect that, not "10x conviction." Not financial advice, and worth its own caveat: oncology immunotherapy outcomes are inherently unpredictable, and I could be wrong about BCME's ability to land a sublicense. But the post you got pitched is misrepresenting the deal structure.

Responsible_Newt9644

BCM is a related party as in the biggest shareholder of OSRH. They’re using their own stake in OSRH as collateral. Do you see this as a risk? Are they propping up the valuation?

saulbenacerraf

ABTS and OSRH will be fun to watch tomorrow

Reasonable-Hedgehog6

OSRH

Dat_Ace

$OSRH hit .90 from this .61 Thread post for 47% move

Dat_Ace

$OSRH hit .90 from this .61 Thread post for 47% move

Dat_Ace

$OSRH hit .90 from this .61 Thread post for 47% move

Dat_Ace

$OSRH hit .90 from this .61 Thread post for 47% move

Dat_Ace

$OSRH hit .90 from this .61 Thread post for 47% move

Competitive-Knee-493

Honestly might be worth a shot, AIXI also had a delist notice by NASDAQ coming to mid June if they didnt hit the $1 mark, now they’re booming, but the news around AIXI is quite significant so it purely depends around the hype around OSRH, if it can bring it to that mark.

Secret_Block_8755

Thoughts on OSRH as a long play? One of their subsidiaries is working with Simopharm to evaluate near-infrared blood monitoring tech in China. Dexcom are another big player in the diabetes space have a 25B market cap, so seems like there's plenty of room for growth if NRI glucose monitoring works out.

Lost_Girl13

Happy Friday $VSA $ONCO $OSRH $GNTA

Odaskills

ELPW - Closed offering BURU - Maddox JV news expected soon AIRE - Trump Homes possibilities OSRH - Recent news

Big_Seesaw_1792

$OSRH

Reasonable-Hedgehog6

OSRH

Boold88

Hey guys. Anyone have thoughts on $OSRH? There are some news, but no major movement in price... do I miss something?

Splendid_muralist

What do we think of OSRH?

Due-Papaya-6217

OSRH loaded up very bigly on this one. Was shorted into to the ground on that binding 815m milestone deal with 30m upfront cash. The shorts won, and are now leaving the building with more shares becoming available. That 30m in cash alone is 2x the current market cap. XAIR only got 1m in cash and 32m in milestones and look how much that got pumped. Nothing on the Woori IO deal, and if that comes this thing will become a multi bagger IMO

Splendid_muralist

OSRH And how about CJMB - Do we think ATON or EVTV will continue?

Teach231

OSRH goes nowhere all day following good news, but now finally moves in the overnight market?

DrblkPres

OSRH merger completed [today](https://www.sec.gov/Archives/edgar/data/1840425/000121390025099393/ea0261472-8k_osrhold.htm)

Broke-colorbone

$OSRH easy money!

Teddy_Rex

Is it worth getting on OSRH now?

Ill-Pack7395

OSRH is my only green. GPUS is unstable again … anyone else have these ?

Due-Papaya-6217

OSRH the shorts must start covering soon. This was a BINDING agreement with 30m cash upfront and $815 million in milestones. I can’t believe what happened today!

Unique_Durian5944

OSRH looks like it’s going to start recovering here soon, I think after hours it will correct if not during the day.

Unique_Durian5944

OSRH was manipulated today almost definitely.